Podcasts about Electrophysiology

Check out the TIES Sales Showdown at www.tx.ag/TIESVisit The Sales Lab at https://thesaleslab.org and check out all our guests' recommended readings at https://thesaleslab.org/reading-listTo listen to The Sales Lab Podcast on your favorite apps, visit https://thesaleslab.simplecast.com/ and select your preferred method of listening.Connect with us on Facebook at https://www.facebook.com/saleslabpodcastConnect with us on Linkedin at https://www.linkedin.com/company/thesaleslabSubscribe to The Sales Lab channel on YouTube at  https://www.youtube.com/channel/UCp703YWbD3-KO73NXUTBI-Q 

Prof. Marina de Koning-Tijssen interviews Professors Anna Latorre and Shabbir Merchant on the topic of electrophysiology, with a focus on cortical myoclonus. Together they discuss the potential applications of electrophysiology for myoclonus in clinical practice. They also explore the complex interface between cortical myoclonus and epilepsy.

With Jean-Claude Deharo, Hospital La Timone Adults, Marseille - France, Professor Fabien Praz, Inselspital Bern - Switzerland, Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia and Vera Maslova, University Medical Center of Schleswig-Holstein, Kiel - Germany. This episode will tackle the EHRA Consensus document on management of patients with transvalvular leads undergoing percutaneous tricuspid clave interventions, focusing on assessment, procedural insights, post-procedure care, and expert perspectives.

Meredith Cochran is a serial entrepreneur with a passion for authentic conversations and high quality craftsmanship. A roll-up-your-sleeves kind of girl. Meredith has a background in Cellular Molecular Biology, Electrophysiology, and Traditional Chinese Medicine. She uses this experience to pursue her passion of preventive health and food-as-medicine. Meredith is an accomplished author and founder of a BFY brand which generates multi-million dollar revenues annually with an omni-channel business model. She is currently focused on her role as Director of Marketing for one of the largest privately-owned businesses in the world and her new startup, which focuses on sustainably sourced teas formulated with the intention of reconnecting us to our body, mind, soul, and those who surround us. In her spare time, she enjoys time with her dog, Maui, bikram yoga, and reading.Elevate Your Brand is the #1 marketing podcast for entrepreneurs and “wantrepreneurs” looking for insider tips and secrets from the most exciting new and growing brands in Los Angeles and the US at large. Each week, entrepreneurial special guests join Laurel Mintz, founder and CEO of award-winning marketing agency Elevate My Brand, to discuss the marketing failures and successes that have brought their brands to the next level. Learn from real-life experiences and be inspired by leaders in your industry about how smart digital and experiential marketing can elevate your brand.Contact us: https://www.elevatemybrand.com/contact Stay connected & DM us feedback on the podcast:Instagram: https://www.instagram.com/elevatemybrandla/ LinkedIn: https://www.linkedin.com/company/elevatemybrandla/ TikTok: https://www.tiktok.com/@elevatemybrand

This special electrophysiology-themed issue of JACC, summarized by Dr. Valentin Fuster, dives into cutting-edge research on atrial fibrillation, pulsed field ablation, sudden cardiac arrest in athletes, and preventive strategies in congenital heart disease. From new therapies like finerenone to breakthrough mapping techniques, this episode captures the evolving sophistication and promise of arrhythmia management in modern cardiology.

With Giovanni Donato Aquaro, University of Pisa - Italy, and Carmelo De Gori, Fondazione Monasterio, Pisa - Italy. Link to editorial Link to paper  

With Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia, Stelios Tzeis, Mitera Hospital, Athens - Greece, and Natasja de Groot, Erasmus University Medical Centre, Rotterdam - The Netherlands, and Dominik Linz, Maastricht University Medical Centre (MUMC), Maastricht - The Netherlands. During this podcast Stefan Simovic, Natasja de Groot, Stylianos Tzeis and Dominik Linz will tackle the EHRA 2025 Highlights  (scientific breakthroughs, major trial results, latest news on in catheter ablation and leadless pacing). 

In this episode, Dr. Valentin Fuster summarizes the March 25, 2025, issue of the JACC, which focuses on advancements in electrophysiology. Highlights include groundbreaking studies on leadless pacemakers, atrial fibrillation treatments, and appropriate use criteria for cardiac devices, with key papers exploring the safety of pacemaker retrieval, the role of electrograms in ablation procedures, and long-term outcomes for left atrial appendage occlusion devices.

This week we review a recent review paper on newest innovations and literature on pacing in pediatric patients and learn a bit about such diverse pediatric pacing topics as:Use of the Medtronic Micra device in an off-label manner for epicardial pacing in small infantsNovel, less invasive approaches to placing epicardial leads in small childrenThe role of leadless pacing in the pediatric or CHD patientConduction system pacing in 2025 in the congenital patientThe above are amongst the potpourri of pacing topics that we review with noted congenital electrophysiologist, Dr. Charles Berul of Children's National Hospital in Washington, DC in a co-branded episode with the SADS Foundation. For more information on SADS, please go to their website: SADS.ORG.DOI: 10.1016/j.hrthm.2024.02.011

With Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia, and Gregory Y.H. Lip, University of Liverpool, Liverpool - UK. This episode will tackle the current status and management of subclinical atrial fibrillation and atrial high rate episodes.

With Federico Fortuni and Claudio Bernetti, University of Perugia, Perugia - Italy Link to paper Link to editorial

Returning for a second study this month, the JHLT Digital Media Editors invite lead author Oliver J.F. Weiner, to discuss the paper, “Sympathetic reinnervation in cardiac transplant recipients: Prevalence, time course, and association with long-term survival.” Dr. Weiner is currently an out of training registrar at Monash Health in Melbourne, Australia, but will soon return to his home of the UK to begin internal medicine training with the intention becoming a cardiologist. He is especially interested in advanced heart failure and electrophysiology. The episode explores: The uncertainty around clinical influences on reinnervation The importance of this single-center study in expanding the literature Potential future treatment options   For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Those on lung transplant teams should check the previous episode for a study on recent trends and post-transplant outcomes from EVLP. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

With Lucas Boersma, St.Antonius Hospital, Nieuwegein - The Netherlands, and Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia. Join us for an exciting episode on non-transvenous ICDs, exploring their advantages and future potential.  

In this episode of "In the Rhythm," we welcome Drs. Hawkins Gay from Northwestern Medicine and Mohamed Elshazly of Orlando Health to explore the transformative role of artificial intelligence in Electrophysiology. Join us as they delve into the innovative ways AI is reshaping the diagnosis, prediction, and treatment of arrhythmias, from enhancing patient outcomes to streamlining clinical workflows.

With Markus Meyer, Lillehei Heart Institute, University of Minnesota - USA, Tim Van Loon and Joost Lumens, Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands. Link to paper Link to editorial

This week we review a recent report that asks the question, 'Do all infants who present with SVT require preventive anti-arrhythmic medical therapy?' Who might be a candidate for not using an anti-arrhythmia medication in infancy? What sort of parental education is needed to potentially not use medicine and how do patients not treated compare to those who were treated with anti-arrhythmics in regards to re-admission or presentation to the emergency department or development of tachycardia induced cardiomyopathy? How should parents assess their infants for SVT at home? How long should infants be monitored prior to discharge to home after a single uncomplicated episode of SVT? We speak with Assistant Professor of Pediatrics at Washington University and the first author of this week's work, Dr. Anthony Pompa. DOI: 10.1007/s00246-023-03263-1

In this episode, EP Lab Digest features a discussion with Bradley Knight, MD, and Nassir Marrouche, MD, about the upcoming Western Atrial Fibrillation Symposium, taking place February 27-March 1, 2025, in Salt Lake City, Utah. For more information about the conference and to register, please visit www.westernaf.com!

With Doctor Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia, Serge Trines, Leiden University Medical Center, Leiden - The Netherlands and Philip Moore, St Bartholomew's Hospital, London - UK This episode focuses on the EHRA Updated Core Curriculum.

With Irene Carrion-Sanchez and Jose Luis Zamorano, Ramon and Cajal University Hospital, Madrid - Spain. Link to paper Link to editorial

Jasmina (Jass) Brooks is President, Electrophysiology, Johnson & Johnson MedTech (formerly Biosense Webster, Inc.), a global leader in the science, diagnosis and treatment of heart rhythm disorders. Jass is a seasoned leader with more than 25 years of experience in the cardiovascular field, primarily focused on electrophysiology. She has accountability for setting the J&J MedTech Electrophysiology end-to-end global strategy as a leader in cardiac ablation, advancing its innovation agenda, and driving execution to position the organization for continued growth. Previously, Jass was Vice President, Global Strategic Marketing, Biosense Webster, Inc. In this role, she worked with cross-functional and international teams to set the strategy and shape the company product pipeline to drive growth, market share, and profitability. Having joined Biosense Webster in 2014, Jass held positions of increasing scope and responsibility in the Global Strategic Marketing Organization. Prior to joining Johnson & Johnson, Jass spent 15 years at GE Healthcare, where she held various roles in commercial marketing, global strategic marketing, product development and engineering in the US and EMEA. She holds a Bachelor of Science in Biomedical Engineering from Louisiana Tech University. Jass has dedicated her career to championing excellence in patient outcomes and solving unmet medical needs. She is a collaborative leader with a deep knowledge of the electrophysiology space, a track record of successfully driving growth and market leadership, as well as a deep commitment to developing talent and fostering a culture of collaboration and inclusivity. In 2023, Jass was named as one of LA Times' Healthcare Visionaries. In 2024, she was honored as one of Orange County Business Journal's Women in STEM and was also celebrated as one of the publications 2024 “OC 500,” an annual Directory of Influence that honors the most impactful leaders, innovators, and changemakers in the OC business community. -- Critical Mass Business Talk Show is Orange County, CA's longest-running business talk show, focused on offering value and insight to middle-market business leaders in the OC and beyond. Hosted by Ric Franzi, business partner at REF Orange County.

With Shinwan Kany, The University Medical Center Hamburg-Eppendorf, Hamburg - Germany, and Shaan Khurshid, Massachusetts General Hospital and Harvard Medical School - USA. Link to paper Link ton editorial

DISCLAMER >>>>>>    The Ditch Lab Coat podcast serves solely for general informational purposes and does not serve as a substitute for professional medical services such as medicine or nursing. It does not establish a doctor/patient relationship, and the use of information from the podcast or linked materials is at the user's own risk. The content does not aim to replace professional medical advice, diagnosis, or treatment, and users should promptly seek guidance from healthcare professionals for any medical conditions.   >>>>>> The expressed opinions belong solely to the hosts and guests, and they do not necessarily reflect the views or opinions of the Hospitals, Clinics, Universities, or any other organization associated with the host or guests.       Disclosures: Ditch The Lab Coat podcast is produced by (Podkind.co) and is independent of Dr. Bonta's teaching and research roles at McMaster University, Temerty Faculty of Medicine and Queens University. Welcome to another episode of "Ditch the Lab Coat," where we break down complex medical science in an engaging and relatable way. In today's episode, our hosts, Dr. Mark Bonta and Dr. Zachary Laksman, dive deep into the nuances of managing atrial fibrillation (AFib). We'll dissect the foundation and challenges of current treatment guidelines, explore the growing role of atrial fibrillation ablation, and discuss the fascinating phenomenon of "Holiday Heart."Dr. Laksman will also share insights from his cutting-edge work at the intersection of genetics and personalized medicine, including the innovative MyTrials AI platform he's co-founded. This tool aims to democratize access to clinical trials using artificial intelligence, making them accessible irrespective of personal networks. We'll cover the emerging potential of wearables in heart rhythm monitoring, the importance of lifestyle interventions, and the evolving landscape of AFib treatment.Whether you're a medical professional or simply curious about heart health, this episode offers valuable perspectives and practical advice. Stay tuned as we unravel these topics and more with the expertise of Dr. Zachary Laksman, an acclaimed heart rhythm specialist and leader in cardiogenetics. Don't forget to check out our new website and engage with us for more insightful content. Let's get started!00:00 - Seek professional advice, not podcast opinions.05:50 - Wearable devices: Reliable, clinically relevant, widely used.08:50 - Heart doctor: Electrician managing heart's nerve impulses.12:50 - Atrial fibrillation increases stroke risk despite rhythm.14:19 - Smartwatch inconsistencies in detecting atrial fibrillation.19:33 - Rhythm control improves life quality and longevity.20:17 - Modifiable and unmodifiable risk factors affect atrial fibrillation.25:56 - Researching interventions for high-risk patient outcomes.28:24 - Lifestyle changes reduce recurrent atrial fibrillation likelihood.31:10 - Shock hearts carefully; consider anticoagulants beforehand.33:52 - Are guidelines fear-mongering or evidence-based?37:55 - Electrophysiology advances improve atrial fibrillation ablation.41:54 - Tailoring medicine to individuals for better outcomes.46:02 - AI aids connection, education, breaking trial barriers.48:43 - Helping people navigate medical concerns and care.53:44 - Heart rhythms, paddles, blood thinners, stroke prevention.55:27 - Zach's AI project expands clinical trial access.

With Arian Sultan, St. Georg Heart Center Asklepios Clinic Hamburg - Germany, Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia and David Duncker,  Hannover Heart Rhythm Center, Hannover - Germany. This episode is a 2024 overview of Arian Sultan's favourite studies. 

With David Duncker, Hannover Heart Rhythm Center, Hannover - Germany, Stefan Simovic, Clinical Center Kragujevac & Faculty of Medical Sciences, University of Kragujevac - Serbia, and John Mandrola, Baptist Health, Louisville - USA. This episode strives for the best evidence together with John Mandrola. 

In this episode, Dr. Kamala Tamirisa, a cardiac electrophysiologist at Texas Cardiac Arrhythmia Institute, discusses the importance of increasing female representation in cardiology, the barriers women face in leadership, and the power of allyship. Dr. Tamirisa shares her insights on fostering an abundance mindset, creating supportive work environments, and mentoring the next generation of women leaders.

This week we review a recent large scale study on catecholaminergic polymorphic ventricular tachycardia (CPVT) in children which is based on two large international registries. How do outcomes differ between those symptomatic CPVT patients treated with or without an ICD? Who amongst symptomatic CPVT pediatric patients likely warrant an ICD? What sort of ICD might be optimal - subcutaneous or transvenous? Are there ways to program ICD's in CPVT patients that may reduce inappropriate shocks? Why should the ICD be rarely employed in the CPVT pediatric patient? These are amongst the questions reviewed this week on the podcast. We speak with the work's senior author, Dr. Shubhayan Sanatani who is the chief of pediatric cardiology at BC Children's Hospital in Vancouver, British Columbia, Canada. doi: 10.1016/j.hrthm.2024.04.006. Epub 2024 Apr 7.

With Viviana Maestrini, Sapienza University of Rome - Italy and Sara Monosilio, Sapienza University of Rome - Italy. Link to paper Link to editorial

This week we listen in on a lecture by Assistant Professor of Pediatrics at the University of Pennsylvania, Dr. Christopher Janson, on the novel agent ivabradine. How does this agent work and in what circumstances can it be used in pediatric arrhythmia management? Is this safe to use for critical arrhythmias despite the fact that it is, at present, only available as an enteral agent? What is the proper dosing regimen with this medication? Dr. Janson answers these and many more questions about ivabradine in this lecture from the Pedirhythm XI conference in Rome, Italy on 9/20/24. 

In this episode, Katie interviews Meredith Cochran. Meredith  is a serial entrepreneur with a passion for authentic conversations and high-quality craftsmanship. Meredith has a Cellular Molecular Biology, Electrophysiology, and Traditional Chinese Medicine background. She uses this experience to pursue her passion for preventive health and food-as-medicine. Meredith is an accomplished author and former CEO/founder of The Osso Good Co., which she grew to an omnichannel business model and millions in revenue. She is currently focused on her role as Founder/CEO of Shareable (www.meredithcochran.com), where she operates as a fractional marketing team for several CPG brands including one of the largest privately-owned businesses in the World (www.pasturebird.com) and her new startup, Tēthos (www.drinktethos.com), which focuses on sustainably sourced teas and na wines. In her spare time, she serves on the board for a nonprofit, Berry Good Food Foundation (www.berrygoodfood.org) aimed at solving food sovereignty in San Diego and Baja.Key Topics Discussed:Overview of Meredith's non-alcoholic wine companyThe inspiration behind creating a healthier wine optionMeredith's transition from her previous career to entrepreneurshipKey challenges faced in the startup process and how she overcame themInsights on how Meredith's products align with a healthier lifestyleDiscussion on the growing demand for non-alcoholic and healthy beverage optionsTips and insights for those looking to start their own businessesThe significance of perseverance and passion in entrepreneurshipLearn more about Tēthos and follow along to join in on the conversation: https://www.instagram.com/drink.tethos/https://drinktethos.com/

With David Duncker, Hannover Heart Rhythm Center, Hannover - Germany, and Janet Han, VA Greater Los Angeles Healthcare and University of California Los Angeles - United States of America. This podcast will tackle gender differences in cardiac arrhythmias and in EP careers. 

Send us a textOne of the most treated heart rhythm disorders in the United States is irregular heart activity known as Atrial Fibrillation or Afib. Dr. Weiwei Li, electrophysiologist at St. Luke's Heart Care Clinic, returns to the podcast to discuss a new treatment option for Afib, Pulsed Field Ablation.To learn more about heart care services at St. Luke's, visit unitypoint.org/cr-heart.Do you have a question about a trending medical topic? Ask Dr. Arnold! Submit your question and it may be answered by Dr. Arnold on the podcast! Submit your questions at: https://www.unitypoint.org/cedarrapids/submit-a-question-for-the-mailbag.aspxIf you have a topic you'd like Dr. Arnold to discuss with a guest on the podcast, shoot us an email at stlukescr@unitypoint.org.

With Raul Santos, Hospital Israelita Albert Einstein, Sao Paulo - Brazil. Link to Editorial Link to Paper

With Kwan-Leung CHAN & Lawrence Lau, University of Ottawa Heart institute - Canada. Link to editorial Link to paper

With David Duncker, Hannover Heart Rhythm Centre, Hannover - Germany, and Helmut Pürerfellner, Ordensklinikum Linz Elisabethinen, Linz - Austria In this episode, the incoming EHRA President, Helmut Pürerfellner, tells us how his EHRA journey started and shares his vision for the next couple of years.

Join us on Logan Health's "To Your Health" as we feature Electrophysiology Nurse Practitioner Aimee Zupicich! Discover the latest in heart health and how Aimee is helping patients live healthier lives. Don't miss this insightful conversation!   

Sometimes experimental results are serendipitous. Listen as Associate Editor Dr. Crystal Ripplinger (University of California, Davis) talks with authors Dr. Nikki Posnack and Devon Guerrelli (both at Children's National Hospital and The George Washington University School of Engineering and Applied Science), along with expert Dr. Silvia Marchiano (University of Washington), about the new research by Guerrelli et al. published in our Call for Papers on Excitation-Contraction Coupling, Electrophysiology, and Arrhythmias. The Posnack Lab typically investigates environmental chemicals and their impact on cardiac function using microelectrode arrays to record electrical signals from human iPS cells. When performing cardiotoxicity experiments, the authors realized that their baseline measurements varied significantly between their different studies, making it difficult to combine datasets. In doing the legwork to identify potential sources of variability and improve their own internal lab protocols, the authors focused on the reproducibility of their experimental measurements using human iPSCs. Listen as we discuss important recommendations for investigators using these cells to improve their experimental reproducibility.   Devon Guerrelli, Jenna Pressman, Shatha Salameh, and Nikki Posnack hiPSC-CM Electrophysiology: Impact of Temporal Changes and Study Parameters on Experimental Reproducibility Am J Physiol Heart Circ Physiol, published June 9, 2024. DOI: 10.1152/ajpheart.00631.2023

This week we delve into the world of electrophysiology and review a recent report from the team at Primary Children's hospital on the use of intravascular ultrasound for EP ablation procedures in children. How is this technology useful for ‘routine' ablations in kids? Are there some forms of tachycardia where its use is more important than others? How does it lower procedural time or improve efficacy? We speak with Dr. Thomas Pilcher, chief of pediatric electrophysiology at Primary Children's about his center's recent report in the use of this technology for ablation in children and those with congenital heart disease. https://doi.org/10.1093/europace/euae047

In this podcast, Dr. Heberton will provide an overview of atrial fibrillation signs and symptoms, how it may be diagnosed and various treatment options available today. Patients are able to live life while managing their AFib, but early diagnosis and the involvement of a specialist trained to treat heart rhythm disorders is key.

This week we go back in time to 20222 to re-review an episode focusing on gender disparities in salary in the field of congenital electrophysiology. To what degree are female electrophysiologists paid less than their male counterparts despite similar levels of education, work effort and seniority? What interventions could be enacted to help 'mind the gap' and level the playing field in this regard? We speak with the chief of pediatric electrophysiology at The Children's Hospital of Philadelphia, Professor Maully Shah, who is the first author of this week's research letter. doi: 10.1016/j.jacep.2022.02.011

Screening echo, multivitamins, wasteful research, another PA sensor for HF, vascular closure devices, and GLP-1 marketing as science research are the topics John Mandrola, MD, discusses this week. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I. Screening for Valvular HD in the Elderly EHJ-CV Imaging Paper https://doi.org/10.1093/ehjci/jeae127 II. Vitamins and Wasteful Research Is Red Meat Healthy? Multiverse Analysis Has Lessons Beyond Meat   https:// www.medscape.com/viewarticle/red-meat-healthy-multiverse-analysis-has-lessons-beyond-meat-2024a10008qv May 10, 2024 This Week in Cardiology Podcast https://www.medscape.com/viewarticle/1000772 Multivitamin Paper https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2820369 Physicians Health Study II https://jamanetwork.com/journals/jama/fullarticle/1389615 III. FDA Has Approved Another PA Sensor Link to slides https://c212.net/c/link/?t=0&l=en&o=4104690-1&h=4197477262&u=https%3A%2F%2Fendotronix.com%2FEndotronix-PROACTIVE-HF-LBCT-THT-2024.pdf&a=here IV. Vascular Closure Devices in Electrophysiology. Vascular Closure Devices Study  https://onlinelibrary.wiley.com/doi/full/10.1111/jce.16345 V. SURMOUNT-OSA SURMOUNT OSA Paper https://www.nejm.org/doi/full/10.1056/NEJMoa2404881 SELECT https://www.nejm.org/doi/full/10.1056/NEJMoa2307563 June 21, 2024 This Week in Cardiology Podcast https://www.medscape.com/viewarticle/1001237 JAMA Systematic Review and Meta-analysis https://jamanetwork.com/journals/jama/fullarticle/2643307 SAVE https://www.nejm.org/doi/full/10.1056/NEJMoa1606599 Norwegian study https://doi.org/10.1016/j.hrthm.2022.06.016 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

Atrial fibrillation ablation therapies have progressed from rather primitive approaches to improved treatments that have emerged in recent years. In this series of our award-winning podcast, we discuss the history of the practice of electrophysiology and improvements that field has experienced.   Moderator: Tomas Villanueva, DO, MBA, FACPE, SFHM Senior Principal Clinical Operations and Quality Vizient Guest: Thomas Munger, MD Chair, Heart Rhythm Division Associate Professor of Medicine Mayo Clinic   Show Notes: [01:06] History of electrophysiology [01:55] Training to become an electrophysiologist [02:44] Electrophysiology and the only organ that moves constantly [04:22] Seizure of the heart [05:22] The discipline of electrophysiology and evolving practice of ablation [07:47) The types of ablation     Links | Resources: To contact Modern Practice: modernpracticepodcast@vizientinc.com Dr. Munger's email: munger.thomas@mayo.edu More information (Vizient): Additional pulsed field ablation resources Information on improving an electrophysiology program (Vizient): Optimizing your EP program     Subscribe Today! Apple Podcasts Amazon Podcasts Android Spotify RSS Feed      

With Torsten Doenst & Philine Fleckenstein, Jena University Hospital, Friedrich Schiller University of Jena - Germany.   Link to paper   Link to editorial

This week we listen in to a wonderful roundtable discussion with 3 of the pioneers in the world of pediatric electrophysiology, namely Dr. John Triedman, Dr. J. Philip Saul and Dr. Edward P. Walsh. All three were 'there at the beginning' and share their memories of how they helped to shape the field of pediatric EP. How did Drs. Walsh and Saul choose to proceed with EP training in a pre-ablation and pre-pediatric EP training era? How did all three decide to start a fellowship program to train the next generation of EP doctors? What sort of 'technology' existed to perform ablations in Boston in the early 1990's and how did these experts come to be the first to perform an RF ablation in any human in Boston? How does the field differ today in comparison to its origins? Amongst their many professional accomplishments, what does each 'guru' view as their greatest professional achievement? These are amongst the many questions posed during a wonderful symposium that was held in Boston on 5/16/24 to celebrate both the 35th anniversary of the EP training program at Boston Children's as well as the milestone birthday of the program's founder, Dr. Edward Walsh. 

With Marta Cvijic & Jana Ambrozic, University Medical Centre Ljubljana - Slovenia. Link to editorial Link to paper  

In this week's podcast, we discuss a work that tries to challenge convention when we review a recent work from the team at Emory University about anticoagulation following left sided ablation of SVT in children. A short course of aspirin is commonly prescribed in this setting but what is the evidence for this? How do patients who receive aspirin fare vs. those who do not? Are there some patients in which aspirin might be more 'useful' than others? Is there adequate equipoise to consider a multicenter trial? Is that even necessary? Joining us to discuss this and more about this topic is Dr. Vincent Palmieri, senior electrophysiology fellow at Children's Healthcare of Atlanta. doi: 10.1016/j.hrthm.2024.01.004.

With Juerg Schwitter, Ambra Masi &  Panagiotis Antiochos, University Hospital Lausanne, Lausanne - Switzerland. Link to editorial Link to paper

Emma is joined by Dr. Adam Goldberg M.D., a Cardiologist at Electrophysiology at Cardiovascular Associates of Charlottesville and at Sentara Martha Jefferson Hospital in Charlottesville, Virginia. In this episode: * Dr. Goldberg shares about his medical training and his exposure to patients with sleep apnea. * Adam explains atrial fibrillation and the irregular rapid heartbeat that people experience with that condition. * Studies showing that management of sleep apnea can improve AFib. * Adam shares the exhaustion he felt being a young doctor and how he was unsure if that was owing to a sleep problem or just working long hours. * Experiencing worsening reflux and Adam's decision to seek treatment after his wife complained about his snoring. * Seeing a pulmonologist at the hospital and being tested for sleep apnea at a hotel specially equipped for sleep studies. * Receiving a diagnosis of severe sleep apnea and being set up on CPAP. Connect with Dr. Goldberg: https://cvilleheart.com/staff/adam-goldberg This episode is sponsored by Aeroflow Sleep - learn more here: ⁠⁠⁠https://www.aeroflowsleep.com⁠⁠ Connect with Emma:⁠⁠⁠ Follow the podcast on Instagram:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠https://www.instagram.com/sleepapneastories⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email Emma at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠sleepapneastories@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠https://www.sleepapneastories.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Order "The 6-Week CPAP Solution Workbook" by Emma Cooksey Click here: ⁠⁠⁠⁠⁠⁠⁠https://a.co/d/1KUzY0O⁠⁠⁠⁠⁠⁠⁠ in the US or search your Amazon store for the title in your country. Disclaimer: This podcast episode includes people with sleep apnea discussing their experiences with medical procedures and devices.  This is for information purposes only and you should consult with your medical professionals before starting or stopping any medication or treatment. --- Support this podcast: https://podcasters.spotify.com/pod/show/emma-cooksey/support

In this episode, we visit with Rebecca Seidel, president of Medtronic's cardiac ablation solutions group, about the future of pulsed-field ablation and what it means for the electrophysiology sector. Host Tom Salemi also visits with biomedical researcher Jeff Karp to discuss his new book, LIT: Life Ignition Tools: Use Nature's Playbook to Energize Your Brain, Spark Ideas, and Ignite Action Kindle Edition. Use the code LIT25 to save 25% off the registration price of DeviceTalks Boston and you could win a free copy. Karp will also be at DeviceTalks Boston's opening reception on April 30. Come meet the author and noted medtech innovator. Finally, we get a #DTBoston2024 speaker preview – Scott Nelson, CEO of FastWave Medical, one of two IVL companies we'll have at the conference! Thank you to Freudenberg Medical for sponsoring this episode. Go to Freudenbergmedical.com for more information. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network

Atrial Fibrillation (AFib), or an irregular heartbeat, is a condition that can lead to stroke, heart failure, and blood clots. A new study has found that drinking diet sodas puts you at a 20% higher risk for AFib. Listen in this week as Dee discusses the results of the study, and how much diet soda per week poses the highest risk.Reference:Sun, Y., Yu, B., Yu, Y., Wang, B., Tan, X., Lu, Y., Wang, Y., Zhang, K., & Wang, N. (2024). Sweetened beverages, genetic susceptibility, and incident atrial fibrillation: A Prospective cohort study. Circulation: Arrhythmia and Electrophysiology, 17(3). https://www.ahajournals.org/doi/10.1161/CIRCEP.123.012145